The Current Ratio as of September 2024 (TTM) for Tyra Biosciences, Inc. (TYRA) is 36.46

According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 36.46. This represents a change of 24.41% compared to the average of 29.31 of the last 4 quarters.

Tyra Biosciences, Inc. (TYRA) Historical Current Ratio (quarterly & annually)

How has TYRA Current Ratio performed in the past?

The mean historical Current Ratio of Tyra Biosciences, Inc. over the last ten years is 30.25. The current 36.46 Current Ratio has changed 11.95% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Current Ratio was at its highest in in the March 2023 quarter at 107.04. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Tyra Biosciences, Inc. (TYRA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tyra Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tyra Biosciences, Inc. (TYRA) Average Current Ratio

How has TYRA Current Ratio performed in the past?

The current Current Ratio of Tyra Biosciences, Inc. (TYRA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tyra Biosciences, Inc. (TYRA) Current Ratio vs. Peers

How is TYRA’s Current Ratio compared to its peers?

Tyra Biosciences, Inc.’s Current Ratio is greater than Connect Biopharma Holdings Limited (4.99), greater than RAPT Therapeutics, Inc. (8.14), greater than Xilio Therapeutics, Inc. (2.02), greater than Mineralys Therapeutics, Inc. (11.20), greater than Gracell Biotechnologies Inc. (7.73), greater than Theseus Pharmaceuticals, Inc. (29.93), greater than Monte Rosa Therapeutics, Inc. (6.56), less than Design Therapeutics, Inc. (41.42), greater than Erasca, Inc. (16.79), greater than Werewolf Therapeutics, Inc. (12.13), greater than Ikena Oncology, Inc. (18.22), greater than Stoke Therapeutics, Inc. (6.67), greater than PMV Pharmaceuticals, Inc. (19.22), greater than Pharvaris N.V. (18.45), greater than Molecular Partners AG (14.58), greater than Century Therapeutics, Inc. (10.62), greater than Edgewise Therapeutics, Inc. (30.24), greater than C4 Therapeutics, Inc. (5.09), greater than Cullinan Oncology, Inc. (28.87),

Build a custom stock screener for Tyra Biosciences, Inc. (TYRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tyra Biosciences, Inc. (TYRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.